To test the effect of inhibiting PHGDH in osteosarcoma cell lines, NCT-503, a small-molecule inhibitor of PHGDH, or an NCT-503-inactive control (NCT-inactive) was used. The gene discussed is PHGDH; the disease is osteosarcoma.